Dong-A Pharmaceutical Q3 Operating Profit Rises 5.37% Year Over Year

Bitget2026/10/27 02:34

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Dong-A Pharmaceutical’s third-quarter 2026 operating profit rose 5.37% year over year to KRW 35.1 billion.
Revenue increased 12.66% from a year earlier to KRW 431.04 billion.
Compared with the previous quarter, operating profit fell 9.92%, while revenue grew 4.52%.
Revenue for January-September 2026 reached KRW 1.19 trillion, up 12.91% year over year.
Operating profit for the nine months increased 13.9% to KRW 93.19 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dong-A Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261027800177), on October 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Dong-A Pharmaceutical Q3 Operating Profit Rises 5.37% Year Over Year

You may also like

Crypto prices